Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

YPrime has announced the launch of its Automated Data Change Form (DCF), an innovative feature within the latest release of ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that Cohort 3 of its Phase 1 clinical trial ...

PhaseV has formed a strategic collaboration with Alimentiv for supporting the design and execution of adaptive clinical ...

ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trialData of on-going Phase 1b also ...

Trish Groves provides an overview of the increasing demand to make clinical trial data transparent. Now such calls to make clinical trial data transparent – along with openly accessible ...

Wave Life Sciences (NASDAQ:WVE) announced clinical trial application approval and initiation of the Phase 1 INLIGHT clinical ...

In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated. As we navigate the complexities of these trials and the ...

WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new ...

Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on ...

GCCL is committed to customer success, emphasizing quality control at every stage—from analysis consulting and sample processing to data management—ensuring efficient clinical trials and research ...

Arena International’s Outsourcing in Clinical Trials West Coast 2025 will discuss patient centricity, diversity, and ...